General Information of the Compound
| Compound ID |
CP0484203
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[(5,6-dichloro-1H-benzimidazol-2-yl)methyl]-2-piperazin-1-yl-9-pyridin-3-ylpurin-6-amine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C22H20Cl2N10
|
||||||||||||||||||
| Molecular Weight |
495.378
|
||||||||||||||||||
| Canonical SMILES |
Clc1cc2nc(CNc3nc(nc4n(cnc34)-c3cccnc3)N3CCNCC3)[nH]c2cc1Cl
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C22H20Cl2N10/c23-14-8-16-17(9-15(14)24)30-18(29-16)11-27-20-19-21(32-22(31-20)33-6-4-25-5-7-33)34(12-28-19)13-2-1-3-26-10-13/h1-3,8-10,12,25H,4-7,11H2,(H,29,30)(H,27,31,32)
Show/Hide
|
||||||||||||||||||
| InChIKey |
NFGOADORCRMUJZ-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01351, Casein kinase I isoform delta
Protein ID: PT01551, Casein kinase I isoform epsilon